However, his PSA level decreased and maintained a decreasing trend for 5 months (Fig. 3 ).
← all excerpts
A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high-risk prostate cancer.
1
—
—
However, his PSA level decreased and maintained a decreasing trend for 5 months (Fig. 3 ).